From: Elevated levels of plasma D-dimer predict a worse outcome in patients with nasopharyngeal carcinoma
Characteristic | DFS (n = 717) | DMFS (n = 717) | OS (n = 717) | ||||||
---|---|---|---|---|---|---|---|---|---|
 | HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P |
Age, (≥47 vs. < 47 years) | 0.73 | 0.51 to 1.06 | 0.100 | 0.87 | 0.56 to 1.33 | 0.517 | 0.85 | 0.56 to 1.29 | 0.444 |
Male vs. Female | 1.08 | 0.71 to 1.65 | 0.726 | 1.48 | 0.86 to 2.54 | 0.162 | 0.92 | 0.64 to 1.65 | 0.922 |
Histology, WHO type (III vs. II) | 0.95 | 0.42 to 2.53 | 0.949 | 0.69 | 0.28 to 1.70 | 0.689 | 1.78 | 0.56 to 5.62 | 0.328 |
ECOG (2 vs. 0–1) | 1.10 | 0.15 to 7.85 | 0.927 | 1.05 | 0.36 to 6.53 | 0.596 | 1.25 | 0.14 to 8.99 | 0.824 |
Clinical stage (III-IV) vs. (I-II) | 3.05 | 1.34 to 6.94 | 0.008 | 4.43 | 1.40 to 14.01 | 0.011 | 2.56 | 1.04 to 6.31 | 0.041 |
Tumour stage (T3-4 vs. T1-2) | 1.47 | 0.93 to 2.31 | 0.100 | 1.65 | 0.94 to 2.88 | 0.08 | 1.32 | 0.80 to 2.18 | 0.286 |
Node stage (N2-3 vs. N0-1) | 1.72 | 1.19 to 2.48 | 0.004 | 2.19 | 1.40 to 3.42 | 0.001 | 1.75 | 1.16 to 2.66 | 0.008 |
Chemoradiotherapy (yes v no) | 1.94 | 0.90 to 4.17 | 0.089 | 1.58 | 0.69 to 3.63 | 0.279 | 1.59 | 0.70 to 3.64 | 0.27 |
IMRT vs. 2DRT/3DCRT | 0.55 | 0.38 to 0.80 | 0.002 | 0.66 | 0.42 to 1.04 | 0.071 | 0.88 | 0.57 to 1.34 | 0.537 |
High DNA Vs. Low DNA | 2.97 | 2.02 to 4.36 | < 0.001 | 3.69 | 2.30 to 5.91 | < 0.001 | 3.50 | 2.23 to 5.50 | < 0.001 |
CRP, mg/L (≥1.61vs. < 1.61) | 1.43 | 0.99 to 2.06 | 0.055 | 1.83 | 1.18 to 2.84 | 0.007 | 1.87 | 1.23 to 2.85 | 0.003 |
VCA-IgA (≥1:80 vs. < 1:80) | 1.39 | 0.91 to 2.13 | 0.127 | 1.32 | 0.81 to 2.16 | 0.267 | 0.95 | 0.64 to 1.61 | 0.952 |
EA-IgA (≥1:10 vs. < 1:10) | 1.23 | 0.85 to 1.77 | 0.282 | 1.17 | 0.76 to 1.81 | 0.477 | 0.99 | 0.66 to 1.50 | 0.977 |
LDH, U/L (≥167 vs. < 167) | 1.41 | 0.98 to 2.04 | 0.064 | 1.67 | 1.07 to 2.59 | 0.002 | 1.38 | 0.92 to 2.08 | 0.125 |
D-dimer, ug/L (≥0.8 vs. < 0.8) | 1.88 | 1.28 to 2.77 | 0.001 | 2.16 | 1.38 to 3.36 | 0.001 | 1.98 | 1.29 to 3.04 | 0.002 |
WBC, 109/L (≥6.7 vs. < 6.7) | 1.06 | 0.90 to 1.25 | 0.753 | 1.17 | 0.76 to 1.9 | 0.481 | 1.08 | 0.72 to 1.62 | 0.709 |
Neutrophil, 109/L (≥4.1 vs. < 4.1) | 1.09 | 0.76 to 1.56 | 0.658 | 1.03 | 0.67 to 1.57 | 0.9 | 1.24 | 0.82 to 1.87 | 0.308 |
HGB, g/l (≥143.8 vs. < 143.8) | 0.87 | 0.61 to 1.25 | 0.463 | 0.82 | 0.53 to 1.25 | 0.35 | 0.77 | 0.51 to 1.16 | 0.207 |
PLT, 109/L (≥227 vs. < 227) | 1.13 | 0.79 to 1.62 | 0.511 | 1.08 | 0.71 to 1.66 | 0.712 | 1.23 | 0.82 to 1.84 | 0.33 |
Smoking (yes vs. no) | 1.27 | 0.88 to 1.84 | 0.196 | 1.59 | 1.04 to 2.44 | 0.033 | 1.22 | 0.81 to 1.84 | 0.346 |
Chronic HBV Infection (yes vs. no) | 1.00 | 0.84 to 1.18 | 0.953 | 1.02 | 0.84 to 1.23 | 0.881 | 0.97 | 0.80 to 1.18 | 0.969 |
cardiovascular disease (yes v no) | 1.16 | 0.61 to 2.22 | 0.653 | 1.28 | 0.62 to 2.67 | 0.5 | 1.64 | 0.79 to 3.41 | 0.184 |
Diabetes mellitus (yes v no) | 0.94 | 0.85 to 1.05 | 0.286 | 0.97 | 0.87 to 1.08 | 0.592 | 0.94 | 0.84 to1.05 | 0.248 |
family history of NPC (yes v no) | 1.14 | 0.61 to 2.11 | 0.686 | 1.13 | 0.55 to 2.35 | 0.735 | 1.14 | 0.92 to 1.41 | 0.241 |